| Income Statement |
| Total Revenue | 81.38M |
|
| Revenues (USD) | 81.38M |
| Cost of Revenue | 35.57M |
| Gross Profit | 45.81M |
| Operating Expenses | 35.86M |
| Research and Development Expense | 1.80M |
| Selling, General and Administrative Expense | 32.49M |
| Operating Income | 9.95M |
| Interest Expense | 1.90M |
| Income Tax Expense | 2.42M |
| Net Income | 4.23M |
| Net Income Common Stock | 4.23M |
| Net Income Common Stock (USD) | 4.23M |
| Consolidated Income | 6.07M |
| Net Income to Non-Controlling Interests | 1.85M |
| Earnings per Basic Share | 0.08 |
| Earnings per Basic Share (USD) | 0.08 |
| Earnings per Diluted Share | 0.07 |
| Earning Before Interest & Taxes (EBIT) | 8.54M |
| Earning Before Interest & Taxes (USD) | 8.54M |
| Weighted Average Shares | 54.13M |
| Weighted Average Shares Diluted | 56.39M |
| Balance Sheet |
| Cash and Equivalents | 146.00M |
| Cash and Equivalents (USD) | 146.00M |
| Investments | 211.95M |
| Trade and Non-Trade Receivables | 108.54M |
| Property, Plant & Equipment Net | 240.89M |
| Total Assets | 893.15M |
| Total Debt | 290.83M |
| Total Liabilities | 464.81M |
| Accumulated Retained Earnings (Deficit) | -235.74M |
| Accumulated Other Comprehensive Income | -8.66M |
| Shareholders Equity | 335.46M |
| Shareholders Equity (USD) | 335.46M |
| Total Debt (USD) | 290.83M |
| Deferred Revenue | 56.13M |
| Goodwill and Intangible Assets | 76.74M |
| Inventory | 35.82M |
| Trade and Non-Trade Payables | 17.19M |
| Tax Assets | 12.68M |
| Tax Liabilities | 12.52M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 15.24M |
| Net Cash Flow from Financing | -2.76M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.17M |
| Capital Expenditure | -6.93M |
| Issuance (Purchase) of Equity Shares | 3.81M |
| Issuance (Repayment) of Debt Securities | 11.84M |
| Net Cash Flow from Investing | -6.93M |
| Net Cash Flow from Operations | 4.03M |
| Effect of Exchange Rate Changes on Cash | 487.00K |
| Share Based Compensation | 5.79M |